Hatice Odabaş (Hatice Odabas)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Topics

Metastatic Renal Cell Carcinoma

Prognostic Factors

Ejection Fraction

Top Venues

Medicina (Kaunas, Lithuania)

Scientific reports

Balkan medical journal

This page only lists publications with an associated author ORCID identifier.

Publications

Nebi Serkan Demirci, Eyyüp Cavdar, Nuriye Yildirim Ozdemir, Sinemis Yuksel, Yakup İriağaç, Gokmen Umut Erdem, Hatice Odabaş, Ilhan Hacibekiroglu, Mustafa Karaagac, Mahmut Ucar, Banu Ozturk, Yakup Bozkaya
Clinicopathologic Analysis and Prognostic Factors for Survival in Patients with Operable Ampullary Carcinoma: A Multi-Institutional Retrospective Experience. Medicina (Kaunas, Lithuania) 60 (5) (2024)
Deniz Işık, Oguzcan Kinikoglu, Goncagul Akdag, Yunus Emre Altıntaş, Ezgi Türkoğlu, Sedat Yildirim, Heves Surmeli, Tuğba Başoğlu, Hatice Odabaş, Nedim Turan
Clinical Effectiveness of Targeted Therapies Following Nivolumab Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-World Study. Medicina (Kaunas, Lithuania) 60 (7) (2024)
Nebi Serkan Demirci, Eyyüp Cavdar, Nuriye Yildirim Ozdemir, Sinemis Yuksel, Yakup İriağaç, Gokmen Umut Erdem, Hatice Odabaş, Ilhan Hacibekiroglu, Mustafa Karaagac, Mahmut Ucar, Banu Ozturk, Yakup Bozkaya
Clinicopathologic Analysis and Prognostic Factors for Survival in Patients with Operable Ampullary Carcinoma: A Multi-Institutional Retrospective Experience. Medicina (Kaunas, Lithuania) 60 (5) (2024)
Oguzcan Kinikoglu, Hatice Odabaş, Yunus Emre Altıntaş, Anıl Yıldız, Burçin Çakan, Goncagül Akdağ, Sedat Yildirim, Hamit Bal, Tuğba Kaya, Salih Tünbekici, Deniz Işık, Tuğba Başoğlu, Mahmut Emre Yildirim, Nedim Turan
Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer. Medicina (Kaunas, Lithuania) 60 (6) (2024)
Deniz Işık, Oguzcan Kinikoglu, Goncagul Akdag, Yunus Emre Altıntaş, Ezgi Türkoğlu, Sedat Yildirim, Heves Surmeli, Tuğba Başoğlu, Hatice Odabaş, Nedim Turan
Clinical Effectiveness of Targeted Therapies Following Nivolumab Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-World Study. Medicina (Kaunas, Lithuania) 60 (7) (2024)
Nebi Serkan Demirci, Eyyüp Cavdar, Nuriye Yildirim Ozdemir, Sinemis Yuksel, Yakup İriağaç, Gokmen Umut Erdem, Hatice Odabaş, Ilhan Hacibekiroglu, Mustafa Karaagac, Mahmut Ucar, Banu Ozturk, Yakup Bozkaya
Clinicopathologic Analysis and Prognostic Factors for Survival in Patients with Operable Ampullary Carcinoma: A Multi-Institutional Retrospective Experience. Medicina (Kaunas, Lithuania) 60 (5) (2024)
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Eyyüp Cavdar, Oguzcan Kinikoglu, Sila Oksuz, Hacer Sahika Yildiz, Aysun Kucukoz Uzun, Deniz Işık, Heves Surmeli, Tugba Basoglu Tuylu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients. Cancers 16 (14) (2024)
Oguzcan Kinikoglu, Hatice Odabaş, Yunus Emre Altıntaş, Anıl Yıldız, Burçin Çakan, Goncagül Akdağ, Sedat Yildirim, Hamit Bal, Tuğba Kaya, Salih Tünbekici, Deniz Işık, Tuğba Başoğlu, Mahmut Emre Yildirim, Nedim Turan
Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer. Medicina (Kaunas, Lithuania) 60 (6) (2024)
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Eyyüp Cavdar, Oguzcan Kinikoglu, Sila Oksuz, Hacer Sahika Yildiz, Aysun Kucukoz Uzun, Deniz Işık, Heves Surmeli, Tugba Basoglu Tuylu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients. Cancers 16 (14) (2024)
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Zeynep Yüksel Yasar, Hamit Bal, Oguzcan Kinikoglu, Sila Oksuz, Ugur Ozkerim, Salih Tunbekici, Hacer Sahika Yildiz, Özkan Alan, Sermin Coban Kokten, Deniz Işık, Heves Surmeli, Tugba Basoglu Tuylu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy. Scientific reports 14 (1) (2024)
Deniz Işık, Oguzcan Kinikoglu, Goncagul Akdag, Yunus Emre Altıntaş, Ezgi Türkoğlu, Sedat Yildirim, Heves Surmeli, Tuğba Başoğlu, Hatice Odabaş, Nedim Turan
Clinical Effectiveness of Targeted Therapies Following Nivolumab Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-World Study. Medicina (Kaunas, Lithuania) 60 (7) (2024)
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Zeynep Yüksel Yasar, Hamit Bal, Oguzcan Kinikoglu, Sila Oksuz, Ugur Ozkerim, Salih Tunbekici, Hacer Sahika Yildiz, Özkan Alan, Sermin Coban Kokten, Deniz Işık, Heves Surmeli, Tugba Basoglu Tuylu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy. Scientific reports 14 (1) (2024)
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Zeynep Yüksel Yasar, Hamit Bal, Oguzcan Kinikoglu, Sila Oksuz, Ugur Ozkerim, Salih Tunbekici, Hacer Sahika Yildiz, Özkan Alan, Sermin Coban Kokten, Deniz Işık, Heves Surmeli, Tugba Basoglu Tuylu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy. Scientific reports 14 (1) (2024)
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Eyyüp Cavdar, Oguzcan Kinikoglu, Sila Oksuz, Hacer Sahika Yildiz, Aysun Kucukoz Uzun, Deniz Işık, Heves Surmeli, Tugba Basoglu Tuylu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients. Cancers 16 (14) (2024)
Sedat Yildirim, Özkan Alan, Zeynep Yüksel Yasar, Tugba Kaya, Goncagul Akdag, Oguzcan Kinikoglu, Gonca Gul Gecmen, Alper Yaşar, Deniz Işık, Heves Surmeli, Tugba Basoglu, Ozlem Nuray Sever, Mahmut Emre Yildirim, Hatice Odabaş, Nedim Turan
Prognostic Impact and Clinical Features of Spread through Air Spaces in Operated Lung Cancer: Real-World Analysis. Medicina (Kaunas, Lithuania) 60 (8) (2024)
Goncagul Akdag, Deniz Işık, Akif Dogan, Sedat Yildirim, Oguzcan Kinikoglu, Alper Topal, Sila Oksuz, Ezgi Turkoglu, Heves Surmeli, Tugba Basoglu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
Does Adjuvant Chemotherapy Benefit Patients with T4 N0 Colon Cancer? Medicina (Kaunas, Lithuania) 60 (8) (2024)
Hatice Odabaş, Akif Dogan, Melike Ozcelik, Sedat Yildirim, Ugur Ozkerim, Nedim Turan, Mahmut Emre Yildirim, Mahmut Gumus
Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer? Medicina (Kaunas, Lithuania) 59 (3) (2023)
Hatice Odabaş, Akif Dogan, Melike Ozcelik, Sedat Yildirim, Ugur Ozkerim, Nedim Turan, Mahmut Emre Yildirim, Mahmut Gumus
Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer? Medicina (Kaunas, Lithuania) 59 (3) (2023)
Goncagul Akdag, Özkan Alan, Akif Dogan, Zeynep Yüksel Yasar, Sedat Yildirim, Oguzcan Kinikoglu, Emre Kudu, Heves Surmeli, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
Outcomes of surveillance versus adjuvant treatment for patients with stage-I seminoma: a single-center experience. World journal of urology (2023)
Hatice Odabaş, Akif Dogan, Melike Ozcelik, Sedat Yildirim, Ugur Ozkerim, Nedim Turan, Mahmut Emre Yildirim, Mahmut Gumus
Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer? Medicina (Kaunas, Lithuania) 59 (3) (2023)
Melike Ozcelik, Özlem Ercelep, Sevinç Keser, Nagehan Özdemir Barışık, Merve Başar, Hatice Odabaş, Abdilkerim Oyman, Selver Isik, Serhat Özçelik, Mehmet Aliustaoğlu
PTK-7 Expression in Gastric Cancer: A Prognostic Determinant Balkan medical journal 37 (2) (2019)